Riskpilot← Back to searchSign inGet full accessDIAFARM A/S
A/SActiveCVR 26638445Ferrarivej 12Manufacture of perfumes and toilet preparations · NACE 2042Est. 200229 employees
Revenue 2024
DKK 362K
-51% vs 2023
EBITDA margin
100.0%
-51% vs 2023
Equity ratio
85.8%
Financial strength
Net profit 2024
DKK 331K
-42% vs 2023
| Revenue | DKK 362K | -51% |
| EBITDA | DKK 362K | -51% |
| Net profit | DKK 331K | -42% |
| Total assets | DKK 3,7M | -21% |
| Equity | DKK 3,2M | -22% |
| Employees | 29 | — |
Legal name
DIAFARM A/S
CVR number
26638445
Legal form
Aktieselskab
NACE code
2042 · Manufacture of perfumes and toilet preparations
Founded
6. juni 2002
Share capital
DKK 500.000
Employees
29 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med salg af fodertilskud og pleje produkter mv. til selskabsdyr (hus og kæledyr) samt produktionsdyr, på det internationale marked
Address
Ferrarivej 12
Phone
+4575828044
Email
finance@diafarm.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.118 | 7.866 | 9.177 | 9.752 | 9.084 | 11.082 | 12.628 | 12.978 | 14.136 | 274 | 333 | 739 | 362 |
| Staff expenses | -5.975 | -6.252 | -7.384 | -7.695 | -8.002 | -8.727 | -10.240 | -10.068 | -12.062 | -0 | -0 | -0 | -0 |
| EBITDA | 1.143 | 1.614 | 1.792 | 2.056 | 1.082 | 2.355 | 2.388 | 2.910 | 2.074 | 274 | 333 | 739 | 362 |
| Depreciation & amort. | -322 | -313 | -286 | -231 | -524 | -505 | -498 | -803 | -303 | -0 | -0 | -0 | -0 |
| EBIT | 822 | 1.301 | 1.506 | 1.825 | 558 | 1.850 | 1.890 | 2.107 | 1.771 | 274 | 333 | 739 | 362 |
| Net financials | -279 | -177 | -168 | -198 | -404 | -332 | -308 | -260 | -206 | -76 | -37 | 32 | 63 |
| Profit before tax | 542 | 1.125 | 1.339 | 1.627 | 154 | 1.518 | 1.582 | 1.847 | 1.566 | 197 | 296 | 772 | 424 |
| Tax | 136 | 280 | 326 | 384 | 55 | 333 | 350 | 408 | 345 | 49 | 65 | 198 | 94 |
| Net profit | 406 | 844 | 1.013 | 1.244 | 99 | 1.186 | 1.233 | 1.439 | 1.220 | 148 | 231 | 574 | 331 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8.309 | 8.726 | 9.829 | 14.962 | 14.039 | 15.092 | 15.272 | 14.611 | 15.990 | 4.914 | 5.081 | 4.673 | 3.692 |
| Equity | 1.407 | 1.951 | 2.214 | 2.708 | 2.057 | 3.242 | 3.475 | 3.914 | 3.484 | 3.632 | 3.863 | 4.036 | 3.167 |
| Long-term debt | 3.033 | 2.911 | 2.789 | 5.636 | 5.409 | 4.790 | 4.454 | 3.791 | 3.591 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.845 | 3.863 | 4.826 | 6.618 | 6.573 | 7.060 | 7.336 | 6.530 | 8.915 | 1.282 | 1.219 | 637 | 525 |
| Total debt | 6.878 | 6.774 | 7.614 | 12.254 | 11.982 | 11.850 | 11.790 | 10.321 | 12.506 | 1.282 | 1.219 | 637 | 525 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
20122024
Return on equity
10.4%
This company
18.4%
Market median
+43% vs market
20122024
Net profit margin
91.4%
This company
8.1%
Market median
+1028% vs market
20122024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20122024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA Management | Management | 2018 | — | — |
JG Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
JG Founder | Founder | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fitzrovia ApS | Company | 90.0% | 90.0% | 2023 |
| Individual | 5.0% | 0.0% | 2020 | |
ROYSTON ApS | Company | 33.3% | 50.0% | 2014 |
PIMLICO ApS | Company | 33.3% | 50.0% | 2014 |
SENA HOLDING ApS | Company | 20.0% | 20.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DIAFARM A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Benny Andersen | Management | 0 companies |
| Jesper Gjelstrup | Chief Executive Officer | 0 companies |
| Johannes Gjelstrup | Founder | 0 companies |
| Peter Vammen | Chairman | 0 companies |
| Jacob Gjelstrup | Board of Directors | 0 companies |
| Steen Nordstrøm | Chairman | 0 companies |
| Allan Christensen | Board of Directors | 0 companies |